WO2001032888A3 - Human transferase molecules - Google Patents

Human transferase molecules Download PDF

Info

Publication number
WO2001032888A3
WO2001032888A3 PCT/US2000/030485 US0030485W WO0132888A3 WO 2001032888 A3 WO2001032888 A3 WO 2001032888A3 US 0030485 W US0030485 W US 0030485W WO 0132888 A3 WO0132888 A3 WO 0132888A3
Authority
WO
WIPO (PCT)
Prior art keywords
htfs
human transferase
transferase molecules
provides
molecules
Prior art date
Application number
PCT/US2000/030485
Other languages
French (fr)
Other versions
WO2001032888A2 (en
Inventor
Y Tom Tang
Henry Yue
Jennifer L Hillman
Preeti Lal
Olga Bandman
Chandra Patterson
Leo L Shih
Yalda Azimzai
Dyung Aina M Lu
Mariah R Baughn
Original Assignee
Incyte Genomics Inc
Y Tom Tang
Henry Yue
Jennifer L Hillman
Preeti Lal
Olga Bandman
Chandra Patterson
Leo L Shih
Yalda Azimzai
Dyung Aina M Lu
Mariah R Baughn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Y Tom Tang, Henry Yue, Jennifer L Hillman, Preeti Lal, Olga Bandman, Chandra Patterson, Leo L Shih, Yalda Azimzai, Dyung Aina M Lu, Mariah R Baughn filed Critical Incyte Genomics Inc
Priority to CA002387785A priority Critical patent/CA2387785A1/en
Priority to AU14664/01A priority patent/AU1466401A/en
Priority to JP2001535570A priority patent/JP2003530079A/en
Priority to EP00976962A priority patent/EP1228222A2/en
Publication of WO2001032888A2 publication Critical patent/WO2001032888A2/en
Publication of WO2001032888A3 publication Critical patent/WO2001032888A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)

Abstract

The invention provides human transferase molecules (HTFS) and polynucleotides which identify and encode HTFS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HTFS.
PCT/US2000/030485 1999-11-04 2000-11-02 Human transferase molecules WO2001032888A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002387785A CA2387785A1 (en) 1999-11-04 2000-11-02 Human transferase molecules
AU14664/01A AU1466401A (en) 1999-11-04 2000-11-02 Human transferase molecules
JP2001535570A JP2003530079A (en) 1999-11-04 2000-11-02 Human transferase molecule
EP00976962A EP1228222A2 (en) 1999-11-04 2000-11-02 Human transferase molecules

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16359599P 1999-11-04 1999-11-04
US60/163,595 1999-11-04

Publications (2)

Publication Number Publication Date
WO2001032888A2 WO2001032888A2 (en) 2001-05-10
WO2001032888A3 true WO2001032888A3 (en) 2002-03-07

Family

ID=22590716

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/030485 WO2001032888A2 (en) 1999-11-04 2000-11-02 Human transferase molecules

Country Status (5)

Country Link
EP (1) EP1228222A2 (en)
JP (1) JP2003530079A (en)
AU (1) AU1466401A (en)
CA (1) CA2387785A1 (en)
WO (1) WO2001032888A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489152B1 (en) * 2000-02-29 2002-12-03 Millennium Pharmaceuticals, Inc. 32670, novel human phosphatidylserine synthase-like molecules and uses thereof
US20020009777A1 (en) * 2000-03-24 2002-01-24 Meyers Rachel A. 25552, a novel human methyltransferase family member and uses thereof
EP1311687A2 (en) * 2000-07-14 2003-05-21 Millennium Pharmaceuticals, Inc. Putative human methyltransferase family member and uses thereof
US20040096868A1 (en) * 2001-04-05 2004-05-20 Zhimin Zhu Regulation of human gnat acetyltransferase-like protein
US20030153018A1 (en) * 2001-11-27 2003-08-14 Millennium Pharmaceuticals, Inc. Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710
WO2005077091A2 (en) * 2004-02-10 2005-08-25 Trustees Of Dartmouth College Nicotinamide riboside kinase compositions and methods for using the same
US20050227327A1 (en) * 2004-02-10 2005-10-13 Brenner Charles M Nicotinamide riboside kinase compositions and methods for using the same
US20110030104A1 (en) 2008-08-29 2011-02-03 Los Alamos National Security, Llc Nucleic acids encoding plant glutamine phenylpyruvate transaminase (GPT) and uses thereof
US20110030089A1 (en) 2008-08-29 2011-02-03 Los Alamos National Security, Llc Transgenic plants with enhanced growth characteristics
WO2010025466A2 (en) * 2008-08-29 2010-03-04 Los Alamos National Security, Llc Transgenic plants with enhanced growth characteristics

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
AHMED N K ET AL: "SOME PROPERTIES OF URIDINE CYTIDINE KINASE EC-2.7.1.48 FROM A HUMAN MALIGNANT LYMPHOMA", CANCER RESEARCH, vol. 39, no. 8, 1979, pages 3102 - 3106, XP000992407, ISSN: 0008-5472 *
DATABASE EMBL 1 February 1997 (1997-02-01), OZAKI K ET AL: "5'-terminal region of UMK", XP002163961 *
DATABASE EMBL 1 November 1996 (1996-11-01), OZAKI K ET AL: "Human mRNA for 5'-terminal region of UMK", XP002163962 *
DATABASE EMBL 2 November 1999 (1999-11-02), LEE N H ET AL: "Bento Soares Rattus cDNA clone; 5' end similar to uridine kinase", XP002163964 *
DATABASE EMBL 28 June 1999 (1999-06-28), NATIONAL CANCER INSTITUTE, CANCER GENOME ANATOMY PROJECT (CGAP): "Homo sapiens cDNA clone, 5'-terminal region of UMK", XP002163963 *
INHAENG YUH ET AL: "Up-regulated uridine kinase gene identified by RLCS in the ventral horn after crush injury to rat sciatic nerves", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS., vol. 266, 1999, ACADEMIC PRESS INC. ORLANDO, FL., US, pages 104 - 109, XP000990179, ISSN: 0006-291X *
ROPP P A ET AL: "Cloning and expression of a cDNA encoding uridine kinase from mouse brain", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, vol. 336, 1996, NEW YORK, US, US, pages 105 - 112, XP000992365, ISSN: 0003-9861 *

Also Published As

Publication number Publication date
JP2003530079A (en) 2003-10-14
CA2387785A1 (en) 2001-05-10
WO2001032888A2 (en) 2001-05-10
AU1466401A (en) 2001-05-14
EP1228222A2 (en) 2002-08-07

Similar Documents

Publication Publication Date Title
WO2001012662A3 (en) Membrane associated proteins
WO1999036550A3 (en) Human protease molecules
WO2000070049A3 (en) Extracellular signaling molecules
WO2003052075A3 (en) Enzymes
WO2000018922A8 (en) Human carbohydrate-associated proteins
WO1999057144A3 (en) Human transcriptional regulator molecules
WO2000014251A3 (en) Human transferase proteins
WO2001072777A3 (en) Human transcription factors
WO2000005374A3 (en) Molecules associated with cell proliferation
WO2000000594A3 (en) Human transferases
WO2000060080A3 (en) Molecules of the immune system
WO2003042357A3 (en) Enzymes
WO2001032888A3 (en) Human transferase molecules
WO2000020604A3 (en) Oxidoreductase molecules
WO2002026950A3 (en) Transferases
WO1999041373A3 (en) Human transport-associated molecules
WO1999038981A3 (en) Human protein kinase molecules
WO2000042201A3 (en) Human peptidases
WO1999057270A3 (en) Human receptor molecules
WO1999049037A3 (en) Protein phosphatase-related molecules
WO2003031939A3 (en) Protein modification and maintenance molecules
WO2001046443A3 (en) Proteases
WO2000000609A3 (en) Molecules associated with apoptosis
WO2000024911A3 (en) Human phospholipases
WO2000071679A3 (en) Human oxidoreductase proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2387785

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 535570

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000976962

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000976962

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000976962

Country of ref document: EP